Patents Assigned to Medical Adhesive Revolution GmbH
  • Patent number: 9375509
    Abstract: The present invention relates to an isocyanate functional prepolymer that can be achieved through a) a reaction of an H functional starter compound having at least one Zerewitinoff active H atom with an alkylene oxide and a comonomer to a preliminary stage bearing hydroxyl groups, wherein said comonomer is selected from the group comprising lactides, glycolides, cyclical dicarboxylic acid anhydrides as well as combinations thereof and wherein said comonomer is integrated through statistical copolymerization into the polymer chain(s) of the preliminary stage bearing hydroxyl groups, and b) a reaction of the preliminary stage bearing hydroxyl groups from step a) with a polyfunctional isocyanate to an isocyanate functional prepolymer. The invention additionally relates to a process for producing this isocyanate functional prepolymer, a tissue adhesive system containing such an isocyanate functional prepolymer and a dispensing system having at least two chambers and this type of tissue adhesive system.
    Type: Grant
    Filed: December 17, 2012
    Date of Patent: June 28, 2016
    Assignee: Medical Adhesive Revolution GmbH
    Inventors: Heike Heckroth, Christoph Eggert, Jörg Hofmann, Klaus Lorenz
  • Patent number: 9254347
    Abstract: The present invention relates to a polyurea system encompassing as component A) isocyanate-functional prepolymers obtainable by reaction of aliphatic isocyanates A1) with polyols A2), which can in particular have a number average molecular weight of ?400 g/mol and an average OH functionality of 2 to 6, as component B) amino-functional compounds of general formula (I) in which X is an organic residue comprising a tertiary amino function, having no Zerewitinoff active hydrogen, R1 is a CH2—COOR3 residue, in which R3 is an organic residue having no Zerewitinoff active hydrogen, a linear or branched C1 to C4 alkyl residue, a cyclopentyl or cyclohexyl residue or H, R2 is an organic residue having no Zerewitinoff active hydrogen, n is an integer ?2 or ?3, in particular for closing, binding, bonding or covering cell tissue, and to a metering system for the polyurea system according to the invention.
    Type: Grant
    Filed: April 17, 2012
    Date of Patent: February 9, 2016
    Assignee: Medical Adhesive Revolution GmbH
    Inventors: Heike Heckroth, Christoph Eggert
  • Patent number: 9051410
    Abstract: The present invention relates to a polyurea system, the use of such a polyurea system for sealing, linking, gluing, or covering of cellular tissue, and a dosing system having two chambers for a polyurea system such as this. The polyurea system comprises as components: A) an isocyanate-functioning prepolymer, which can be derived by reacting aliphatic isocyanates with polyoles, and B) an amino-functioning ester of aspartic acid. According to the invention, water and/or tertiary amine is added to the system, in order to increase the reacting speed of the prepolymer with the amino-functioning ester of aspartic acid while decreasing the setting time at the same time.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: June 9, 2015
    Assignee: Medical Adhesive Revolution GmbH
    Inventors: Heike Heckroth, Hartmut Nefzger, Christoph Eggert
  • Patent number: 9000089
    Abstract: Polyurea systems comprising: (a) an amino-functional aspartic ester of the general formula (I) wherein X represents an n-valent organic radical derived from a corresponding n-functional primary amine X(NH2)n, R1 and R2 each independently represent an organic radical having no Zerevitinov active hydrogens and n represents an integer of at least 2; and (b) an isocyanate functional prepolymer having a residual monomer content of less than 1% by weight, the prepolymer prepared by reacting: (b1) an aliphatic isocyante; and (b2) a polyol component having a number average molecular weight of ?400 g/mol and an average OH functionality of 2 to 6, wherein the polyol component comprises one or more constituents selected from the group consisting of polyester polyols, polyester-polyether polyols and mixtures thereof; processes for making the same; postoperative adhesions barriers prepared therewith and dispensing systems for such polyurea systems.
    Type: Grant
    Filed: February 13, 2009
    Date of Patent: April 7, 2015
    Assignee: Medical Adhesive Revolution GmbH
    Inventors: Heike Heckroth, Hartmut Nefzger, Christian Wamprecht
  • Publication number: 20140357828
    Abstract: The present invention relates to a compound of a formula (I) in which R1, R2, R3 are respectively independent equal or various organic radicals that have no Zerewitinoff active hydrogen, R4 are independently hydrogen, equal or different organic radicals, having no Zerewitinoff active hydrogen, or together form an unsaturated or aromatic ring, which can potentially contain heteroatoms, wherein R4 have no Zerewitinoff active hydrogen, X is a linear or branched, potentially even a substituted organic radical in the chain with heteroatom, which does not have Zerewitinoff active hydrogen, n 0<n?2 and m 0?m<2, wherein n+m=2. The invention also relates to a process for producing a compound of said formula (I) as well as a polyurea system containing such a compound.
    Type: Application
    Filed: January 4, 2013
    Publication date: December 4, 2014
    Applicant: Medical Adhesive Revolution GmbH
    Inventors: Christoph Eggert, Heike Heckroth